KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,504 | +349.0% | 47,183 | +466.7% | 0.02% | +466.7% |
| Q2 2023 | $335 | -72.0% | 8,326 | -70.3% | 0.00% | -78.6% |
| Q1 2023 | $1,198 | +77.0% | 28,054 | +98.9% | 0.01% | +75.0% |
| Q4 2022 | $677 | -99.8% | 14,105 | +75.7% | 0.01% | +100.0% |
| Q3 2022 | $302,000 | -14.7% | 8,026 | -37.3% | 0.00% | 0.0% |
| Q2 2022 | $354,000 | +121.2% | 12,797 | +334.7% | 0.00% | +300.0% |
| Q1 2022 | $160,000 | +1.3% | 2,944 | +9.0% | 0.00% | 0.0% |
| Q4 2021 | $158,000 | -45.1% | 2,701 | -62.9% | 0.00% | 0.0% |
| Q3 2021 | $288,000 | +71.4% | 7,283 | +167.3% | 0.00% | 0.0% |
| Q1 2021 | $168,000 | +9.8% | 2,725 | -33.3% | 0.00% | 0.0% |
| Q2 2020 | $153,000 | – | 4,087 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |